SLC18A2 and attention deficit-hyperactivity disorder: Furthermore, by abrogation of vesicular DA packaging via selective targeting of VMAT2 in TrpV1+ neurons, we identify a role in mediating the behavioral response to the psychostimulant amphetamine, a substance often clinically prescribed to alleviate symptoms in ADHD but which is also used/misused and can cause addiction.